labtech diagnostics mayo medical laboratories

At closing, $65 million in initial consideration was payable to AltheaDx security holders, consisting of $32.5 million in cash and $32.5 million in common stock.

Under the terms of the agreement, the pharmacogenomics firm became a wholly-owned subsidiary of Castle.

During Q1 2022, the company recorded a $7 million increase to goodwill, a $3 million increase to customer-related intangible assets, and a $10 million increase to the estimated contingent consideration liability.Ĭastle Biosciences said this week that it has completed its acquisition of AltheaDx. Quest Diagnostics said in its 10-Q filed with the US Securities and Exchange Commission last week that it has revised the purchase price of Labtech Diagnostics, which it acquired last year. Separately, Korean medical artificial intelligence company Vuno said last week that it will collaborate with the Mayo Clinic to develop machine learning and artificial intelligence technologies to identify predictive and prognostic biomarkers in hopes of improv ing diagnosis and treatment of cancer. The laboratory expansion project follows recent announcements of investments at Mayo Clinic in Florida and across the Mayo Clinic Health System. Construction has started and will continue through 2025. The expansion will include new laboratory space for five clinical testing labs and Mayo Clinic Biopharma Diagnostics an expanded and updated cafeteria for laboratory staff and new laboratory support staff spaces at its Superior Drive Support Center.

NEW YORK – Mayo Clinic said this week that it is investing $49 million to expand its laboratory in Rochester, Minnesota.

Labtech diagnostics mayo medical laboratories